- Ongoing, recruitingPhase II and Phase III (Integrated)
A3921145 - A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)
This study is looking at the long-term safety and effects of a medicine called tofacitinib for treating juvenile idiopathic arthritis (JIA) in young people. Researchers will check things like growth, overall health, and how well the medicine controls their JIA.
For: Juvenile Idiopathic Arthritis (JIA)Spain · Belgium · Poland - Active not recruitingPHASE3
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
This study is looking at a medicine called tofacitinib for children aged 2-17 with a bowel condition called ulcerative colitis. It aims to see how well it works, how safe it is, and how the body uses it, especially if other treatments haven't worked.
For: Ulcerative ColitisUnited States · Australia · Belgium